The Nordic meeting 2020 is postponed to February 2022
In light of the current situation with the Covid-19 pandemic, the NFCF organizing committee has decided to postpone The Nordic Meeting to 2022.
Our meeting will have participants and speakers from many nations that may not be able to attend in 2021. It is also uncertain which national restrictions will be enforced; closed borders and limitations of social gatherings, are likely.
New dates for the Nordic Meeting 2022:
The Nordic Meeting 2022 will be held on Thursday to Friday, February 10th and 11th.
The Basic Flow Cytometry course will be held on Wednesday, February 9th.
Place; Oslo, X meeting point (www.xmeetingpoint.no) / Moxy Hotel (same as planned for the meeting in 2020).
The Nordic Flow Cytometry Meeting 2022 is now open for registration!
The Norwegian Society for Flow Cytometry (NFCF) has the pleasure of inviting you to the Nordic Flow Cytometry Meeting 2022. We are organizing a joint Nordic flow cytometry meeting in collaboration with the Danish and Swedish Societies for Flow Cytometry. The meeting will be held at the conference center, X Meeting Point, just outside Oslo.
Venue: X meeting point, Skjetten, Oslo (30 min bus ride from Oslo Airport Gardermoen).
xmeetingpoint.no
———————————————————————————————————–
ESCCA (European Society for Cell Cycle Analysis) samarbeider med NFCF om et møte i Bergen til høsten, 18.-21. September 2019.
For mer informasjon klikk her
———————————————————————————————————-
Nordisk møte i 2017, København
I 2017 tok det Danske Selskab for Flowcytometri initiativ til et felles nordisk møte, sammen med Norsk Flowcytometri Forening og Svensk Forening for Flødescytometri i København høst 2017. NFCF takker for et meget vellykket og lærerikt møte.
Flow entusiaster fra ulike fagfelt deltok på Workshops og postersessions, samt godt arrangerte sosiale arrangementer i København. På dette møtet fikk vi lært masse om flowcytometri av kjente forelesere og via et eget flowcytometrikurs av meget god kvalitet. Kurset ble holdt av Rui Gardner, Memorial Sloan Kettering Cancer Center, USA, Andrew Filby, Newcastle University, UK and Karen Hogg, University of York, UK.
———————————————————————————————————-